Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.55 |
| ▸ | TLR7 | Q9NYK1 | 14/20 | 0.47 |
| ▸ | IRAK4 | Q9NWZ3 | 4/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | PIM1 | P11309 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18170033 | 1.00 | CHEK1 (0.55) | CHEK1TLR7IRAK4NPC1RAB9A | |
| Formic Acid SCHEMBL18169747 | 0.96 | CHEK1 (0.52) | CHEK1TLR7IRAK4NPC1RAB9A | |
| Formic Acid SCHEMBL29687272 | 0.96 | CHEK1 (0.52) | CHEK1TLR7IRAK4NPC1RAB9A | |
| SCHEMBL18169641 | 0.85 | CHEK1 (0.54) | CHEK1TLR7IRAK4NPC1RAB9A | |
| SCHEMBL29610051 | 0.83 | CHEK1 (0.52) | CHEK1TLR7IRAK4NPC1RAB9A | |
| SCHEMBL29611087 | 0.83 | CHEK1 (0.52) | CHEK1TLR7IRAK4NPC1RAB9A | |
| SCHEMBL18169623 | 0.83 | CHEK1 (0.52) | CHEK1TLR7IRAK4NPC1RAB9A | |
| SCHEMBL18169783 | 0.83 | CHEK1 (0.52) | CHEK1TLR7IRAK4NPC1RAB9A | |
| SCHEMBL18169987 | 0.82 | CHEK1 (0.53) | CHEK1TLR7IRAK4PIM1 | |
| SCHEMBL29611065 | 0.82 | CHEK1 (0.53) | CHEK1TLR7IRAK4PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118510771-A | IRAK inhibitors for the treatment of conditions associated with cytokine release associated with respiratory viral infection | 里格尔药品股份有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-114698370-A | Compounds and methods for treating cytokine release syndrome | 里格尔药品股份有限公司 | 2022-07-01 | — | — | CN | disclosed |